Associations of low grade inflammation and endothelial dysfunction with depression - The Maastricht Study

Brain, Behavior, and Immunity

Volumn 56, Issue , 2016, Pages 390-396

  van Dooren, Fleur E P ^a,c,d   Schram, Miranda T ^a,b   Schalkwijk, Casper G ^a,b   Stehouwer, Coen D A ^a,b   Henry, Ronald M A ^a,b   Dagnelie, Pieter C ^b,d   Schaper, Nicolaas C ^a,b,d   van der Kallen, Carla J H ^a,b   Koster, Annemarie ^d   Sep, Simone J S ^a,b   Denollet, Johan ^c   Verhey, Frans R J ^d   Pouwer, Frans ^c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c TILBURG UNIVERSITY   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Depression; Endothelial dysfunction; Inflammation; Lifestyle factors

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR; BIOLOGICAL MARKER;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DEPRESSION; ENDOTHELIAL DYSFUNCTION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT HEALTH QUESTIONNAIRE 9; PRIORITY JOURNAL; SMOKING; BLOOD; COHORT ANALYSIS; MIDDLE AGED; NETHERLANDS; PATHOPHYSIOLOGY; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

AGED; BIOMARKERS; COHORT STUDIES; DEPRESSION; DEPRESSIVE DISORDER; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NETHERLANDS; VASCULAR DISEASES;

EID: 84974694573     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2016.03.004     Document Type: Article

References (55)

1. Aird W.C. Phenotypic heterogeneity of the endothelium. I. Structure, function, and mechanisms. Circ. Res. 2007, 100:158-173.
2. Alexopoulos G.S., Meyers B.S., Young R.C., Campbell S., Silbersweig D., Charlson M. 'Vascular depression' hypothesis. Arch. Gen. Psychiatry 1997, 54:915-922.
3. APA Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington, DC. fourth ed.
4. Banks W.A. The blood-brain barrier in psychoneuroimmunology. Neurol. Clin. 2006, 24:413-419.
5. Belmaker R.H., Agam G. Major depressive disorder. N. Engl. J. Med. 2008, 358:55-68.
6. Berk M., Williams L.J., Jacka F.N., O'Neil A., Pasco J.A., Moylan S., Allen N.B., Stuart A.L., Hayley A.C., Byrne M.L., Maes M. So depression is an inflammatory disease, but where does the inflammation come from?. BMC Med. 2013, 11:200.
7. Boden J.M., Fergusson D.M. Alcohol and depression. Addiction 2011, 106:906-914.
8. Church D.F., Pryor W.A. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ. Health Perspect. 1985, 64:111-126.
9. Cooper D.C., Tomfohr L.M., Milic M.S., Natarajan L., Bardwell W.A., Ziegler M.G., Dimsdale J.E. Depressed mood and flow-mediated dilation: a systematic review and meta-analysis. Psychosom. Med. 2011, 73:360-369.
10. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
11. de Jager J., Dekker J.M., Kooy A., Kostense P.J., Nijpels G., Heine R.J., Bouter L.M., Stehouwer C.D. Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes: the Hoorn Study. Arterioscler. Thromb. Vasc. Biol. 2006, 26:1086-1093.
12. Do D.P., Dowd J.B., Ranjit N., House J.S., Kaplan G.A. Hopelessness, depression, and early markers of endothelial dysfunction in U.S. adults. Psychosom. Med. 2010, 72:613-619.
13. Goldston K., Baillie A.J. Depression and coronary heart disease: a review of the epidemiological evidence, explanatory mechanisms and management approaches. Clin. Psychol. Rev. 2008, 28:288-306.
14. Greenberg P.E., Fournier A.A., Sisitsky T., Pike C.T., Kessler R.C. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J. Clin. Psychiatry 2015, 76:155-162.
15. Harris K.F., Matthews K.A. Interactions between autonomic nervous system activity and endothelial function: a model for the development of cardiovascular disease. Psychosom. Med. 2004, 66:153-164.
16. Hemingway H., Shipley M., Mullen M.J., Kumari M., Brunner E., Taylor M., Donald A.E., Deanfield J.E., Marmot M. Social and psychosocial influences on inflammatory markers and vascular function in civil servants (the Whitehall II study). Am. J. Cardiol. 2003, 92:984-987.
17. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 2009, 71:171-186.
18. Iantorno M., Campia U., Di Daniele N., Nistico S., Forleo G.B., Cardillo C., Tesauro M. Gut hormones and endothelial dysfunction in patients with obesity and diabetes. Int. J. Immunopathol. Pharmacol. 2014, 27:433-436.
19. Imhof A., Froehlich M., Brenner H., Boeing H., Pepys M.B., Koenig W. Effect of alcohol consumption on systemic markers of inflammation. Lancet 2001, 357:763-767.
20. Kiowski W., Linder L., Stoschitzky K., Pfisterer M., Burckhardt D., Burkart F., Buhler F.R. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation 1994, 90:27-34.
21. Kohler O., Benros M.E., Nordentoft M., Farkouh M.E., Iyengar R.L., Mors O., Krogh J. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry 2014, 71:1381-1391.
22. Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9: validity of a brief depression severity measure. J. Gen. Intern. Med. 2001, 16:606-613.
23. Lavoie K.L., Pelletier R., Arsenault A., Dupuis J., Bacon S.L. Association between clinical depression and endothelial function measured by forearm hyperemic reactivity. Psychosom. Med. 2010, 72:20-26.
24. Lesperance F., Frasure-Smith N., Theroux P., Irwin M. The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am. J. Psychiatry 2004, 161:271-277.
25. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F., Feldman H.I., Kusek J.W., Eggers P., Van Lente F., Greene T., Coresh J., Ckd E.P.I. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 2009, 150:604-612.
26. Luger T.M., Suls J., Vander Weg M.W. How robust is the association between smoking and depression in adults? A meta-analysis using linear mixed-effects models. Addict. Behav. 2014, 39:1418-1429.
27. Luppino F.S., de Wit L.M., Bouvy P.F., Stijnen T., Cuijpers P., Penninx B.W., Zitman F.G. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch. Gen. Psychiatry 2010, 67:220-229.
28. Maes M., Galecki P., Chang Y.S., Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:676-692.
29. Maes M., Song C., Lin A., De Jongh R., Van Gastel A., Kenis G., Bosmans E., De Meester I., Benoy I., Neels H., Demedts P., Janca A., Scharpe S., Smith R.S. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine 1998, 10:313-318.
30. McEvoy J.W., Nasir K., DeFilippis A.P., Lima J.A., Bluemke D.A., Hundley W.G., Barr R.G., Budoff M.J., Szklo M., Navas-Acien A., Polak J.F., Blumenthal R.S., Post W.S., Blaha M.J. Relationship of cigarette smoking with inflammation and subclinical vascular disease: the multi-ethnic study of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2015, 35:1002-1010.
31. Moylan S., Maes M., Wray N.R., Berk M. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol. Psychiatry 2013, 18:595-606.
32. Oladeji B.D., Gureje O. The comorbidity between depression and diabetes. Curr. Psychiatry Rep. 2013, 15:390.
33. Park H.S., Park J.Y., Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res. Clin. Pract. 2005, 69:29-35.
34. Raison C.L., Rutherford R.E., Woolwine B.J., Shuo C., Schettler P., Drake D.F., Haroon E., Miller A.H. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 2013, 70:31-41.
35. Riemer S., Maes M., Christophe A., Rief W. Lowered omega-3 PUFAs are related to major depression, but not to somatization syndrome. J. Affect. Disord. 2010, 123:173-180.
36. Romeo H.E., Tio D.L., Rahman S.U., Chiappelli F., Taylor A.N. The glossopharyngeal nerve as a novel pathway in immune-to-brain communication: relevance to neuroimmune surveillance of the oral cavity. J. Neuroimmunol. 2001, 115:91-100.
37. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
38. Schiepers O.J., Wichers M.C., Maes M. Cytokines and major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29:201-217.
39. Schiltz J.C., Sawchenko P.E. Distinct brain vascular cell types manifest inducible cyclooxygenase expression as a function of the strength and nature of immune insults. J. Neurosci. 2002, 22:5606-5618.
40. Schram M.T., Sep S.J., van der Kallen C.J., Dagnelie P.C., Koster A., Schaper N., Henry R.M., Stehouwer C.D. The Maastricht Study: an extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities. Eur. J. Epidemiol. 2014, 29:439-451.
41. Schram M.T., Stehouwer C.D. Endothelial dysfunction, cellular adhesion molecules and the metabolic syndrome. Horm. Metab. Res. 2005, 37(Suppl. 1):49-55.
42. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59(Suppl. 20):22-33. quiz 34-57.
43. Sherwood A., Hinderliter A.L., Watkins L.L., Waugh R.A., Blumenthal J.A. Impaired endothelial function in coronary heart disease patients with depressive symptomatology. J. Am. Coll. Cardiol. 2005, 46:656-659.
44. Stehouwer C.D., Gall M.A., Twisk J.W., Knudsen E., Emeis J.J., Parving H.H. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 2002, 51:1157-1165.
45. Teragawa H., Fukuda Y., Matsuda K., Higashi Y., Yamagata T., Matsuura H., Chayama K. Effect of alcohol consumption on endothelial function in men with coronary artery disease. Atherosclerosis 2002, 165:145-152.
46. Tomfohr L.M., Martin T.M., Miller G.E. Symptoms of depression and impaired endothelial function in healthy adolescent women. J. Behav. Med. 2008, 31:137-143.
47. Valkanova V., Ebmeier K.P., Allan C.L. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J. Affect. Disord. 2013, 150:736-744.
48. van Sloten T.T., Schram M.T., Adriaanse M.C., Dekker J.M., Nijpels G., Teerlink T., Scheffer P.G., Pouwer F., Schalkwijk C.G., Stehouwer C.D., Henry R.M. Endothelial dysfunction is associated with a greater depressive symptom score in a general elderly population: the Hoorn Study. Psychol. Med. 2013, 1-14.
49. van Sloten T.T., Schram M.T., Adriaanse M.C., Dekker J.M., Nijpels G., Teerlink T., Scheffer P.G., Pouwer F., Schalkwijk C.G., Stehouwer C.D., Henry R.M. Endothelial dysfunction is associated with a greater depressive symptom score in a general elderly population: the Hoorn Study. Psychol. Med. 2014, 44:1403-1416.
50. Vischer U.M. Von Willebrand factor, endothelial dysfunction, and cardiovascular disease. J. Thromb. Haemost. 2006, 4:1186-1193.
51. Vitkovic L., Konsman J.P., Bockaert J., Dantzer R., Homburger V., Jacque C. Cytokine signals propagate through the brain. Mol. Psychiatry 2000, 5:604-615.
52. WHO, 2015. http://www.who.int/mediacentre/factsheets/fs369/en/.
53. Willerson J.T., Ridker P.M. Inflammation as a cardiovascular risk factor. Circulation 2004, 109:II2-II10.
54. Yudkin J.S., Stehouwer C.D., Emeis J.J., Coppack S.W. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler. Thromb. Vasc. Biol. 1999, 19:972-978.
55. Zunszain P.A., Anacker C., Cattaneo A., Carvalho L.A., Pariante C.M. Glucocorticoids, cytokines and brain abnormalities in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:722-729.